These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6692267)

  • 1. Biological markers for breast carcinoma.
    Waalkes TP; Enterline JP; Shaper JH; Abeloff MD; Ettinger DS
    Cancer; 1984 Feb; 53(3 Suppl):644-51. PubMed ID: 6692267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R; Caffier H
    Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
    Tormey DC; Waalkes TP; Snyder JJ; Simon RM
    Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of CEA in breast cancer.
    Gray BN
    Aust N Z J Surg; 1984 Feb; 54(1):1-2. PubMed ID: 6586160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
    Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
    Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of biochemical tests to screen for metastases in patients with breast cancer.
    Coombes RC; Powles TJ; Gazet JC; Nash AG; Ford HT; McKinna A; Neville AM
    Lancet; 1980 Feb; 1(8163):296-7. PubMed ID: 6101748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
    Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
    Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen as a monitor of recurrent breast cancer.
    Lee YT
    J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer.
    Wang DY; Knyba RE; Bulbrook RD; Millis RR; Hayward JL
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):25-31. PubMed ID: 6537913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
    Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
    Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control.
    Staab HJ; Ahlemann LM; Anderer FA; Zwirner M; Schindler AE
    Cancer Detect Prev; 1985; 8(1-2):35-45. PubMed ID: 4064050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma.
    Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA
    Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
    Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
    J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.